MedPath

A clinical trial to study the effects of Enhanced recovery after surgery protocol vs conventional care surgery in patients undergoing open Radical cystectomy with ileal conduit.

Not yet recruiting
Conditions
Malignant neoplasm of bladder, unspecified,
Registration Number
CTRI/2021/05/033777
Lead Sponsor
PGIMER
Brief Summary

This study is a randomised ,parallel group  trial , comparing effect of enhanced recovery after surgery (ERAS)protocol in patients undergoing radical cystectomy and urinary diversion  in 54 patients  for 14 months , will be conducted in P.G.I.M.E&R, CHANDIGARH,INDIA.The primary outcome measures effect of ERAS on length of  hospital stay  and secondary outcomes measures  time to appearence of bowel movement and passage of flatus and stool, time to drain removal, perioperative complication according to clavien dindo classification , 30 days readmission rate .

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
54
Inclusion Criteria

ALL PATIENTS UNDERGOING OPEN RADICAL CYSTECTOMY WITH URINARY DIVERSION.

Exclusion Criteria
  • Patients who will not give consent for inclusion in the study 2.History of prior radiotherapy 3.
  • Patients planned for retentive diversions like ONB or CCD 4.
  • Patient with other concomitant malignancy 5.
  • Patient with gastrointestinal disease affecting feeding.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effect of ERAS on length of hospital stayPrimary outcome will be variable according to recovery of patient
Secondary Outcome Measures
NameTimeMethod
1.Time to appearance of bowel movement and passage of flatus2.Time to drain removal

Trial Locations

Locations (1)

PGIMER

🇮🇳

Chandigarh, CHANDIGARH, India

PGIMER
🇮🇳Chandigarh, CHANDIGARH, India
DR ANUP BISWAS
Principal investigator
9681152697
anup4cnmc@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.